These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29555465)

  • 1. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
    Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
    Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.
    Weng YC; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Chen CM; Hwang JS; Kuo HC
    J Diabetes Res; 2020; 2020():6356459. PubMed ID: 32695829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential associations between selenoprotein P and distal sensorimotor polyneuropathy in people with and without diabetes: KORA F4/FF4 study.
    Herder C; Saito Y; Spagnuolo MC; Maalmi H; Shimizu M; Bönhof GJ; Suzuki K; Rathmann W; Peters A; Roden M; Ziegler D; Thorand B; Takamura T
    Free Radic Biol Med; 2024 Oct; 223():87-95. PubMed ID: 39059514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.
    Ziegler D; Strom A; Bönhof GJ; Kannenberg JM; Heier M; Rathmann W; Peters A; Meisinger C; Roden M; Thorand B; Herder C
    BMJ Open Diabetes Res Care; 2019; 7(1):e000752. PubMed ID: 31803481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study.
    Herder C; Thorand B; Strom A; Rathmann W; Heier M; Koenig W; Morrison H; Ziegler D; Roden M; Peters A; Bönhof GJ; Maalmi H
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3807. PubMed ID: 38872492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological serum bilirubin concentrations are inversely associated with the prevalence of cardiovascular autonomic neuropathy in patients with Type 2 diabetes.
    Chung JO; Cho DH; Chung DJ; Chung MY
    Diabet Med; 2014 Feb; 31(2):185-91. PubMed ID: 24147832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening tests for distal symmetrical polyneuropathy in Latin American patients with type 2 diabetes mellitus.
    Gómez-Banoy N; Cuevas V; Soler F; Pineda MF; Mockus I
    Arch Endocrinol Metab; 2017; 61(5):470-475. PubMed ID: 28724059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
    Aso Y; Iijima T; Jojima T; Saito M; Tanuma D; Kase M; Sakurai S; Tomaru T; Usui I
    Postgrad Med; 2024 Apr; 136(3):318-324. PubMed ID: 38660919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of clinical alternatives to nerve conduction studies for screening for diabetic distal symmetrical polyneuropathy: A multi-center study.
    Zhao Z; Ji L; Zheng L; Yang L; Yuan H; Chen L; Shan Z; Shen S; Li Q; Shi B; Liu Y; Ji Q; Bao Y; Gao X; Xie Y; Liu Y; Chen L; Han X; Wu F; Yang C; Du J; Gao Y; Zou D
    Diabetes Res Clin Pract; 2016 May; 115():150-6. PubMed ID: 27116903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.
    Kim ES; Lee SW; Mo EY; Moon SD; Han JH
    Endocrine; 2015 Nov; 50(2):405-12. PubMed ID: 25846483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy.
    Xiong Q; Lu B; Ye HY; Liu SY; Zheng HP; Zhang RY; Qiao XN; Zhang S; Liu XX; Li QC; Yi N; Wu LC; Wen J; Zhang TS; Li YM
    Diabetes Res Clin Pract; 2018 Feb; 136():85-92. PubMed ID: 29221815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
    Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
    Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist.
    Pafili K; Trypsianis G; Papazoglou D; Maltezos E; Papanas N
    Curr Vasc Pharmacol; 2020; 18(1):50-56. PubMed ID: 30156161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.
    Dyck PJ; O'Brien PC; Litchy WJ; Harper CM; Klein CJ; Dyck PJ
    Diabetes Care; 2005 Sep; 28(9):2192-200. PubMed ID: 16123489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERFORMANCE OF TWO DIFFERENT CLINICAL SCORING SYSTEMS IN DIAGNOSING DISTAL SENSORY POLYNEUROPATHY IN PATIENTS WITH TYPE-2 DIABETES.
    Khan FF; Numan A; Khawaja KI; Atif A; Fatima A; Masud F
    J Ayub Med Coll Abbottabad; 2015; 27(1):187-91. PubMed ID: 26182773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.